» Articles » PMID: 37517521

Early-versus Late-onset Sepsis in Neonates - Time to Shift the Paradigm?

Overview
Publisher Elsevier
Date 2023 Jul 30
PMID 37517521
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Neonatal sepsis is traditionally classified as early-onset sepsis (EOS) and late-onset sepsis (LOS) disease categories. This paradigm was based on observed epidemiological data from high income settings. However, increasing availability of microbiology results from diverse settings challenges these assumptions, necessitating re-examination of neonatal sepsis classifications.

Objectives: To review the literature describing the aetiology of EOS and LOS in hospitalized neonates with stratification of pathogen spectrum by low- (LIC), middle- (MIC) and high-income (HIC) country settings, to critically re-examine the continued appropriateness of the 'EOS vs. LOS' sepsis paradigm in all settings.

Sources: PubMed was searched for peer-reviewed English full-text articles published from inception up until 8 August 2022.

Content: Studies often report on either EOS or LOS, rather than both. We identified only 49 original articles reporting on pathogen distribution of both EOS and LOS in the same hospital setting. Clear differences in sepsis aetiology were shown between LIC, MIC and HIC settings, with increasing importance of Klebsiella pneumoniae and decreasing importance of Group B Streptococcus in the first 72 hours of life in LIC and MIC.

Implications: The concept of 'EOS vs. LOS' may be less useful for predicting the pathogen spectrum of neonatal sepsis in LIC and MIC, but the paradigm has shaped reporting of neonatal sepsis, and our understanding. Future neonatal sepsis reporting should utilize strengthening the reporting of observational studies in epidemiology for newborn infection (STROBE-NI) reporting guidelines and clearly describe timing of infection by day, and variation in pathogen spectrum across the neonatal period. Data identified in this review challenge the generalizability of the prevailing EOS/LOS paradigm in LIC and MIC.

Citing Articles

Recent advances and challenges in metal-based antimicrobial materials: a review of strategies to combat antibiotic resistance.

Zhu C, Diao Z, Yang Y, Liao J, Wang C, Li Y J Nanobiotechnology. 2025; 23(1):193.

PMID: 40059157 PMC: 11892188. DOI: 10.1186/s12951-025-03249-6.


Gut microbe-derived betulinic acid alleviates sepsis-induced acute liver injury by inhibiting macrophage NLRP3 inflammasome in mice.

Tang X, Zeng T, Deng W, Zhao W, Liu Y, Huang Q mBio. 2025; 16(3):e0302024.

PMID: 39887250 PMC: 11898617. DOI: 10.1128/mbio.03020-24.


Antibiotic Prescription Practice and Resistance Patterns of Bacterial Isolates from a Neonatal Intensive Care Unit: A Retrospective Study from Jordan.

Alameri M, Gharaibeh L, Alsous M, Yaghi A, Tanash A, Said S Antibiotics (Basel). 2025; 14(1.

PMID: 39858390 PMC: 11762691. DOI: 10.3390/antibiotics14010105.


A Quantitative Examination and Comparison of the Ability of Australian Gentamicin Dosing Guidelines to Achieve Target Therapeutic Concentrations in Neonates.

Grzeskowiak L, Wynne S, Stark M Antibiotics (Basel). 2025; 14(1).

PMID: 39858334 PMC: 11759765. DOI: 10.3390/antibiotics14010048.


Early onset neonatal bloodstream infections in South African hospitals.

Theron G, Bekker A, Bolton L, Whitelaw A, Engelbrecht A, Erasmus L BMC Infect Dis. 2025; 25(1):85.

PMID: 39833703 PMC: 11744941. DOI: 10.1186/s12879-024-10406-z.